Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention.

Hubacek J, Basran RS, Shrive FM, Shewchuk L, Goodhart DM, Anderson TJ; Foothills Interventional Cardiology Service Research Group.

Can J Cardiol. 2009 Feb;25(2):e42-7.

2.

An administrative data merging solution for dealing with missing data in a clinical registry: adaptation from ICD-9 to ICD-10.

Southern DA, Norris CM, Quan H, Shrive FM, Galbraith PD, Humphries K, Gao M, Knudtson ML, Ghali WA; APPROACH Investigators.

BMC Med Res Methodol. 2008 Jan 23;8:1. doi: 10.1186/1471-2288-8-1.

3.

Prognostic implication of hyperglycemia in myocardial infarction and primary angioplasty.

Worthley MI, Shrive FM, Anderson TJ, Traboulsi M.

Am J Med. 2007 Jul;120(7):643.e1-7.

PMID:
17602940
4.

Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis.

Graham AJ, Shrive FM, Ghali WA, Manns BJ, Grondin SC, Finley RJ, Clifton J.

Ann Thorac Surg. 2007 Apr;83(4):1257-64. Review.

PMID:
17383322
5.

Use of the U.S. and U.K. scoring algorithm for the EuroQol-5D in an economic evaluation of cardiac care.

Shrive FM, Ghali WA, Johnson JA, Donaldson C, Manns BJ.

Med Care. 2007 Mar;45(3):269-73.

PMID:
17304086
6.

Dealing with missing data in a multi-question depression scale: a comparison of imputation methods.

Shrive FM, Stuart H, Quan H, Ghali WA.

BMC Med Res Methodol. 2006 Dec 13;6:57.

7.

Public versus private institutional performance reporting: what is mandatory for quality improvement?

Guru V, Fremes SE, Naylor CD, Austin PC, Shrive FM, Ghali WA, Tu JV; Cardiac Care Network of Ontario.

Am Heart J. 2006 Sep;152(3):573-8.

PMID:
16923433
8.

Revascularization in patients with heart failure.

Tsuyuki RT, Shrive FM, Galbraith PD, Knudtson ML, Graham MM; APPROACH Investigators.

CMAJ. 2006 Aug 15;175(4):361-5.

9.

The prognostic importance of nonsignificant left main coronary artery disease in patients undergoing percutaneous coronary intervention.

Gyenes G, Shrive FM, Graham MM, Ghali WA, Knudtson ML; APPROACH Investigators.

J Am Coll Cardiol. 2006 Jul 18;48(2):276-80. Epub 2006 Jun 21.

10.

Association between completeness of percutaneous coronary revascularization and postprocedure outcomes.

McLellan CS, Ghali WA, Labinaz M, Davis RB, Galbraith PD, Southern DA, Shrive FM, Knudtson ML; Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators.

Am Heart J. 2005 Oct;150(4):800-6.

PMID:
16209985
11.

Moving beyond the cost per quality-adjusted life year: modelling the budgetary impact and clinical outcomes associated with the use of sirolimus-eluting stents.

Shrive FM, Ghali WA, Lewis S, Donaldson C, Knudtson ML, Manns BJ.

Can J Cardiol. 2005 Jul;21(9):783-7. Review.

PMID:
16082437
12.

Simultaneous carotid endarterectomy and coronary artery bypass surgery in Canada.

Hill MD, Shrive FM, Kennedy J, Feasby TE, Ghali WA.

Neurology. 2005 Apr 26;64(8):1435-7.

PMID:
15851737
13.

Economic evaluation of sirolimus-eluting stents.

Shrive FM, Manns BJ, Galbraith PD, Knudtson ML, Ghali WA; APPROACH Investigators.

CMAJ. 2005 Feb 1;172(3):345-51.

14.

In-hospital outcomes after percutaneous coronary intervention in Canada: 1992/93 to 2000/01.

Jamal SM, Shrive FM, Ghali WA, Knudtson ML, Eisenberg MJ; Canadian Cardiovascular Outcomes Research Team (CCORT).

Can J Cardiol. 2003 Jun;19(7):782-9.

PMID:
12813611
15.

Outcomes after coronary artery bypass graft surgery in Canada: 1992/93 to 2000/01.

Ghali WA, Quan H, Shrive FM, Hirsch GM; Canadian Cardiovascular Outcomes Research Team.

Can J Cardiol. 2003 Jun;19(7):774-81.

PMID:
12813610

Supplemental Content

Loading ...
Support Center